AVTR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $15.81

Capitalizzazione di Mercato $10.78B

P/E (TTM) -18.8

EPS (TTM) $-0.84

Ricavi (TTM) $6.56B

ROE (TTM) -9.7%

D/E Debito/Patrimonio (MRQ) 0.7

Intervallo 52 sett. $7–$16

AVTR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Avantor, Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

History

The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.

That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.

The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”

Leggi di più Mostra meno

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealthcare industriaLife Sciences Tools & Services dipendenti13.500 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$6.55B

2017-12-31 → 2025-12-31

EPS$-0.78

2018-12-31 → 2025-12-31

Flusso di cassa libero$495M

2019-12-31 → 2025-12-31

Margine netto-8.8%

2019-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-18.8media 5 anni ≈24.9	≈24.9	·	·
P/S	1.6media 5 anni ≈2.2	≈2.2	3.7	Sottovalutato
P/B	1.9media 5 anni ≈3.2	≈3.2	3.6	Sottovalutato
EV / EBITDA	-58.3media 5 anni ≈10.3	≈10.3	·	·
Price / FCF (Prezzo / FCF)	21.8media 5 anni ≈21.7	≈21.7	·	·
Price / Cash Flow (Prezzo / Flusso di cassa)	17.3media 5 anni ≈18.2	≈18.2	25.2	Sottovalutato
EV / Revenue (EV / Ricavi)	2.2media 5 anni ≈2.9	≈2.9	·	·
EV / FCF	29.0media 5 anni ≈28.9	≈28.9	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
Margine lordo (TTM)	31.8%media 5 anni ≈33.7%	≈33.7%	54.2%	Debole
Margine Operativo (TTM)	-4.6%media 5 anni ≈10.1%	≈10.1%	9.2%	Sotto la media
EBITDA Margin (Margine EBITDA)	-3.8%media 5 anni ≈10.1%	≈10.1%	8.3%	Debole
Margine ante imposte (TTM)	-7.2%media 5 anni ≈6.7%	≈6.7%	5.9%	Sotto la media
Margine di Profitto Netto (TTM)	-8.8%media 5 anni ≈4.8%	≈4.8%	2.4%	In linea
ROA (TTM)	-4.7%media 5 anni ≈2.7%	≈2.7%	-0.14%	Debole
ROE (TTM)	-9.7%media 5 anni ≈7.6%	≈7.6%	-0.40%	Debole
ROIC	-3.1%media 5 anni ≈5.1%	≈5.1%	1.1%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.7media 5 anni ≈1.1	≈1.1	0.7	In linea
Rapporto corrente (MRQ)	1.8media 5 anni ≈1.6	≈1.6	3.0	Bassa liquidità
Quick Ratio	1.0media 5 anni ≈0.9	≈0.9	1.6	Sotto la media
Debito a lungo termine / Patrimonio netto (MRQ)	0.7media 5 anni ≈1.0	≈1.0	0.7	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-3.4%media 5 anni ≈0.78%	≈0.78%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-4.5%media 5 anni ≈-1.4%	≈-1.4%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	0.49%	·	·	·
EPS YoY	121.3%media 5 anni ≈232.8%	≈232.8%	·	·
Net Income YoY (Utile Netto YoY)	121.6%media 5 anni ≈119.8%	≈119.8%	·	·
EPS CAGR 3Y (CAGR EPS 3 anni)	7.0%	·	·	·
Net Income CAGR 3Y (CAGR Utile Netto 3 anni)	7.5%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.78media 5 anni ≈$0.52	≈$0.52	·	·
Revenue / Share (Ricavi / Azione)	$9.63media 5 anni ≈$10.64	≈$10.64	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$0.92media 5 anni ≈$1.25	≈$1.25	·	·
Cash / Share (Liquidità / Azione)	$0.54media 5 anni ≈$0.47	≈$0.47	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	AVTR	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.5media 5 anni ≈0.6	≈0.6	0.5	In linea
Inventory Turnover (Rotazione delle scorte)	5.7media 5 anni ≈5.7	≈5.7	2.5	Di prim'ordine
Receivables Turnover (Rotazione dei crediti)	6.2media 5 anni ≈6.2	≈6.2	5.7	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)	≈$485.3K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 0.49%

Prossimo report Ott 27, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Lug 30, 2026	$0.21	$0.19	8.6%
31 Marzo 2026		$0.17	$0.16	6.2%
31 Dicembre 2025		$0.22	$0.22	-0.36%
30 Settembre 2025		$0.22	$0.23	-4.0%
30 Giugno 2025		$0.24	$0.25	-5.1%
31 Marzo 2025		$0.23	$0.24	-2.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	$5.86B	$1.25B
Cost of Revenue	$4.41B	$4.50B	$4.60B	$4.91B	$4.88B	$4.31B	$4.12B	$4.04B	$815M
Gross Profit	$2.14B	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B	$1.92B	$1.82B	$433M
SG&A Expense	$1.60B	$1.64B	$1.51B	$1.47B	$1.53B	$1.37B	$1.37B	$1.41B	$450M
Operating Income	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	$414M	$-210M
Interest Expense	·	·	$285M	$266M	$217M	$308M	$440M	$524M	$201M
Interest Income	$42M	$75M	$65M	$16M	$2M	·	·	·	·
Other Non-op	$-21M	$-1M	$6M	$-800.0K	$11M	$10M	$2M	$-4M	$8M
Pretax Income	$-441M	$854M	$410M	$851M	$753M	$62M	$41M	$-114M	$-460M
Income Tax	$89M	$142M	$89M	$165M	$180M	$-54M	$3M	$-27M	$-315M
Net Income	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	$-87M	$-113M
EPS (Basic)	$-0.78	$1.05	$0.48	$1.02	$0.86	$0.09	$-0.84	$-2.69	·
EPS (Diluted)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	$-2.69	·
Shares (Basic)	680,600,000	679,600,000	675,600,000	650,900,000	590,500,000	576,300,000	401,200,000	132,700,000	·
Shares (Diluted)	680,600,000	681,900,000	678,400,000	679,400,000	599,600,000	583,400,000	401,200,000	132,700,000	·
EBITDA	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	·	·

Stato Patrimoniale 26

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$365M	$262M	$263M	$373M	$302M	$287M	$187M	$185M	·
Receivables	$1.07B	$1.03B	$1.15B	$1.22B	$1.22B	$1.11B	$989M	$931M	·
Inventory	$818M	$732M	$828M	$914M	$872M	$740M	$711M	$671M	·
Other Current Assets	$193M	$119M	$144M	$153M	$81M	$91M	$135M	$113M	·
Current Assets	$2.45B	$2.15B	$2.38B	$2.66B	$2.48B	$2.23B	$2.02B	$1.90B	·
PP&E (Net)	$767M	$708M	$738M	$727M	$706M	$550M	$557M	$599M	·
PP&E (Gross)	$1.51B	$1.34B	$1.35B	$1.25B	$1.15B	$938M	$865M	$824M	·
Accum. Depreciation	$745M	$630M	$617M	$518M	$445M	$388M	$308M	$226M	·
Goodwill	$4.99B	$5.54B	$5.72B	$5.65B	$5.34B	$2.86B	$2.77B	$2.78B	$2.85B
Intangibles	$3.10B	$3.27B	$3.68B	$4.04B	$5.05B	$3.96B	$4.13B	$4.47B	·
Other Non-current Assets	$396M	$360M	$358M	$294M	$233M	$217M	$205M	$63M	·
Total Assets	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Accounts Payable	$742M	$663M	$626M	$758M	$755M	$679M	$560M	$557M	·
Current Liabilities	$1.38B	$2.01B	$1.48B	$1.66B	$1.45B	$1.24B	$1.07B	$1.10B	·
Capital Leases	$152M	$143M	$88M	$87M	$79M	·	$107M	·	·
Deferred Tax	$557M	$557M	$613M	$731M	$913M	$724M	$785M	$908M	·
Other Non-current Liabilities	$378M	$358M	$350M	$295M	$358M	$398M	$428M	$318M	·
Total Liabilities	$6.23B	$6.16B	$7.72B	$8.61B	$9.70B	$7.23B	$7.31B	$9.10B	·
Long-term Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	$6.92B	·
Total Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	·	·
Retained Earnings	$1.67B	$2.20B	$1.49B	$1.17B	$484M	$-89M	$-204M	$-238M	·
Treasury Stock	$76M	$0	·	·	·	·	·	·	·
AOCI	$-17M	$-184M	$-69M	$-100M	$-43M	$22M	$-86M	$-66M	$26M
Stockholders' Equity	$5.57B	$5.96B	$5.25B	$4.86B	$4.20B	$2.67B	$2.46B	$-3.05B	$-2.62B
Liabilities + Equity	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Shares Outstanding	682,000,000	680,800,000	676,600,000	674,300,000	609,700,000	580,100,000	572,800,000	132,800,000	·

Flusso di cassa 18

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$410M	$406M	$402M	$406M	$379M	$395M	$399M	$405M	$99M
Stock-based Comp	$46M	$47M	$40M	$46M	$51M	$44M	$68M	$18M	$48M
Deferred Tax	$8M	$-47M	$-172M	$-69M	$-18M	$-88M	$-107M	$-104M	$-431M
Amort. of Intangibles	$301M	$300M	$308M	$318M	$291M	$308M	$312M	$321M	$65M
Restructuring	$30M	$83M	$26M	$4M	$5M	$12M	$24M	$81M	$30M
Operating Cash Flow	$624M	$841M	$870M	$844M	$954M	$930M	$354M	$200M	$-168M
CapEx	$129M	$149M	$146M	$133M	$111M	$62M	$52M	$38M	$25M
Investing Cash Flow	$-130M	$439M	$-144M	$-110M	$-4.12B	$-59M	$-42M	$-23M	$-6.68B
Debt Issued	$1.11B	$0	$0	$327M	$2.83B	$3.94B	$1M	$36M	$9.25B
Net Debt Issued	$-319M	$-1.34B	$-846M	$-620M	$2.30B	$-423M	$-1.88B	·	·
Stock Issued	·	·	$0	$0	$967M	$0	$4.24B	·	·
Stock Repurchased	$75M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-75M	·	$0	$0	$967M	·	·	·	·
Financing Cash Flow	$-409M	$-1.28B	$-844M	$-649M	$3.22B	$-783M	$-308M	$-170M	$6.96B
Net Change in Cash	$104M	$-23M	$-109M	$70M	$38M	$100M	$2M	$-800.0K	$122M
Taxes Paid	$145M	$248M	$224M	$257M	$145M	$43M	$112M	$66M	$32M
Free Cash Flow	$495M	$692M	$724M	$710M	$842M	$868M	$302M	·	·
Levered FCF	·	·	$501M	$496M	$677M	$292M	$-107M	·	·

Redditività 8

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	32.6%	33.6%	33.9%	34.6%	33.9%	32.5%	31.8%	·	·
Operating Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
Net Margin	-8.1%	10.5%	4.6%	9.1%	7.8%	1.8%	0.63%	·	·
Pretax Margin	-6.7%	12.6%	5.9%	11.3%	10.2%	0.97%	0.67%	·	·
EBITDA Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
ROA	-4.4%	5.7%	2.4%	5.0%	4.8%	1.2%	0.38%	·	·
ROE	-8.9%	12.4%	6.2%	14.5%	13.8%	4.5%	1.6%	·	·
ROIC	-3.1%	9.0%	5.1%	8.2%	6.6%	17.5%	6.8%	·	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	1.8	1.1	1.6	1.6	1.7	1.8	1.9	·	·
Quick Ratio	1.0	0.6	1.0	1.0	1.1	1.1	1.1	·	·
Debt / Equity	0.7	0.7	1.1	1.3	1.7	1.8	2.1	·	·
LT Debt / Equity	0.7	0.5	1.0	1.2	1.7	1.8	2.0	·	·
Interest Coverage	·	·	2.4	4.3	4.5	2.3	1.3	·	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	·	·
Inventory Turnover	5.7	5.8	5.3	5.5	6.1	5.9	6.0	·	·
Receivables Turnover	6.2	6.2	5.9	6.2	6.3	6.1	6.3	·	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$8.16	$8.75	$7.76	$7.20	$6.88	$4.61	$4.30	·	·
Revenue / Share	$9.63	$9.95	$10.27	$11.06	$12.32	$10.96	·	·	·
Cash Flow / Share	$0.92	$1.23	$1.28	$1.24	$1.59	$1.59	·	·	·
Cash / Share	$0.54	$0.38	$0.39	$0.55	$0.49	$0.49	$0.33	·	·
EPS (TTM)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	·	·

Tassi di Crescita 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-3.4%	-2.6%	-7.3%	1.7%	15.5%	·	·	·	·
Revenue CAGR 3Y	-4.5%	-2.8%	2.9%	·	·	·	·	·	·
Revenue CAGR 5Y	0.49%	·	·	·	·	·	·	·	·
EPS YoY	·	121.3%	-53.5%	18.8%	844.4%	·	·	·	·
EPS CAGR 3Y	·	7.0%	73.5%	·	·	·	·	·	·
Net Income YoY	·	121.6%	-53.2%	19.9%	391.1%	·	·	·	·
Net Income CAGR 3Y	·	7.5%	40.2%	·	·	·	·	·	·

Valutazione (TTM) 13

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	·	·
Net Income TTM	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	·	·
Market Cap	$7.82B	$14.34B	$15.45B	$14.22B	$25.69B	$16.33B	$10.40B	·	·
Enterprise Value	$11.40B	$18.14B	$20.72B	$20.14B	$32.41B	$20.94B	$15.33B	·	·
P/E	-14.7	20.3	48.6	20.9	49.6	312.8	-21.6	·	·
P/S	1.2	2.1	2.2	1.9	3.5	2.6	1.7	·	·
P/B	1.4	2.4	2.9	2.9	6.1	6.1	4.2	·	·
P / Cash Flow	12.5	17.1	17.8	16.9	26.9	17.6	29.4	·	·
P / FCF	15.8	20.7	21.3	20.0	30.5	18.8	34.4	·	·
EV / EBITDA	-46.3	16.7	29.8	17.8	33.3	29.6	27.8	·	·
EV / FCF	23.0	26.2	28.6	28.4	38.5	24.1	50.7	·	·
EV / Revenue	1.7	2.7	3.0	2.7	4.4	3.3	2.5	·	·
Earnings Yield	-6.8%	4.9%	2.1%	4.8%	2.0%	0.32%	-4.6%	·	·

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1.69B	$1.58B	$1.66B	$1.62B	$1.68B	$1.58B	$1.69B	$1.71B	$1.70B	$1.68B	$1.72B	$1.72B	$1.74B	$1.78B	$1.79B	$1.86B
Cost of Revenue	$1.16B	$1.08B	$1.14B	$1.10B	$1.13B	$1.05B	$1.12B	$1.15B	$1.12B	$1.11B	$1.15B	$1.14B	$1.15B	$1.16B	$1.18B	$1.21B
Gross Profit	$537M	$501M	$524M	$526M	$554M	$535M	$563M	$564M	$582M	$570M	$570M	$579M	$590M	$625M	$614M	$651M
SG&A Expense	$415M	$401M	$392M	$390M	$425M	$388M	$371M	$440M	$406M	$424M	$387M	$368M	$358M	$394M	$363M	$375M
Operating Income	$122M	$100M	$126M	$-649M	$129M	$147M	$638M	$125M	$176M	$146M	$183M	$210M	$72M	$231M	$252M	$276M
Interest Expense	$39M	$43M	·	$44M	$43M	$42M	·	$49M	$61M	$64M	·	$72M	$73M	$74M	·	$67M
Interest Income	$10M	$10M	$11M	$12M	$11M	$8M	$12M	$27M	$18M	$18M	$18M	$17M	$16M	$14M	·	·
Other Non-op	$-600.0K	$-500.0K	$-1M	$4M	$-4M	$-20M	$-5M	$700.0K	$2M	$1M	$2M	$700.0K	$2M	$600.0K	$-6M	$3M
Pretax Income	$81M	$56M	$81M	$-690M	$82M	$86M	$584M	$74M	$115M	$81M	$120M	$136M	$-1M	$156M	$175M	$208M
Income Tax	$43M	$12M	$28M	$22M	$17M	$21M	$84M	$17M	$22M	$20M	$21M	$28M	$6M	$34M	$33M	$41M
Net Income	$38M	$43M	$52M	$-712M	$65M	$64M	$500M	$58M	$93M	$60M	$98M	$108M	$-7M	$122M	$142M	$167M
EPS (Basic)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.74	$0.08	$0.14	$0.09	$0.15	$0.16	$-0.01	$0.18	$0.20	$0.25
EPS (Diluted)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.73	$0.08	$0.14	$0.09	$0.14	$0.16	$-0.01	$0.18	$0.20	$0.25
Shares (Basic)	676,200,000	675,700,000	·	681,700,000	681,500,000	681,100,000	·	680,300,000	679,400,000	678,100,000	·	676,000,000	675,300,000	674,700,000	·	674,100,000
Shares (Diluted)	677,200,000	676,800,000	·	681,700,000	681,800,000	682,400,000	·	683,000,000	682,600,000	681,400,000	·	678,500,000	675,300,000	678,100,000	·	679,300,000
EBITDA	$122M	$100M	·	$-649M	$129M	$147M	·	$125M	$176M	$146M	·	$210M	$72M	$231M	·	$276M

Stato Patrimoniale 26

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$307M	$279M	$365M	$252M	$449M	$316M	$262M	$285M	$273M	$235M	·	$237M	$236M	$295M	·	$266M
Receivables	$1.14B	$1.10B	$1.07B	$1.08B	$1.15B	$1.10B	$1.03B	$1.09B	$1.13B	$1.13B	·	$1.15B	$1.22B	$1.28B	·	$1.23B
Inventory	$829M	$810M	$818M	$796M	$780M	$750M	$732M	$780M	$796M	$811M	·	$850M	$890M	$904M	·	$905M
Other Current Assets	$188M	$210M	$193M	$132M	$136M	$120M	$119M	$136M	$132M	$146M	·	$147M	$156M	$152M	·	$158M
Current Assets	$2.46B	$2.40B	$2.45B	$2.26B	$2.51B	$2.28B	$2.15B	$2.50B	$2.33B	$2.32B	·	$2.38B	$2.50B	$2.63B	·	$2.56B
PP&E (Net)	$772M	$766M	$767M	$762M	$759M	$736M	$708M	$723M	$754M	$740M	·	$698M	$698M	$736M	·	$698M
PP&E (Gross)	·	·	$1.51B	·	·	·	$1.34B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$787M	$766M	$745M	$724M	$700M	$663M	$630M	$621M	$657M	$635M	·	$580M	$565M	$541M	·	$489M
Goodwill	$4.94B	$4.95B	$4.99B	$4.98B	$5.76B	$5.61B	$5.54B	$5.67B	$5.66B	$5.67B	$5.72B	$5.64B	$5.69B	$5.68B	$5.65B	$5.51B
Intangibles	$2.92B	$3.01B	$3.10B	$3.17B	$3.26B	$3.24B	$3.27B	$3.43B	$3.49B	$3.57B	·	$3.70B	$3.80B	$3.98B	·	$4.01B
Other Non-current Assets	$412M	$442M	$396M	$406M	$391M	$368M	$360M	$420M	$368M	$368M	·	$289M	$277M	$272M	·	$245M
Total Assets	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Accounts Payable	$743M	$736M	$742M	$692M	$709M	$680M	$663M	$674M	$657M	$573M	·	$656M	$687M	$766M	·	$769M
Current Liabilities	$1.38B	$1.37B	$1.38B	$1.52B	$2.58B	$2.03B	$2.01B	$1.63B	$1.46B	$1.44B	·	$1.49B	$1.55B	$1.67B	·	$1.55B
Capital Leases	·	·	$152M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Deferred Tax	$540M	$550M	$557M	$548M	$536M	$550M	$557M	$547M	$575M	$601M	·	$649M	$663M	$696M	·	$728M
Other Non-current Liabilities	$383M	$377M	$378M	$403M	$391M	$365M	$358M	$419M	$362M	$361M	·	$271M	$269M	$300M	·	$334M
Total Liabilities	$5.97B	$6.07B	$6.23B	$6.11B	$6.49B	$6.23B	$6.16B	$7.29B	$7.26B	$7.43B	·	$7.70B	$8.05B	$8.40B	·	$8.52B
Long-term Debt	$3.70B	$3.82B	$3.95B	$3.86B	$4.24B	$4.11B	$4.06B	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Total Debt	$3.70B	$3.82B	·	$3.86B	$4.24B	$4.11B	·	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Retained Earnings	$1.75B	$1.72B	$1.67B	$1.62B	$2.33B	$2.27B	$2.20B	$1.70B	$1.64B	$1.55B	·	$1.39B	$1.28B	$1.29B	·	$1.03B
Treasury Stock	$76M	$76M	$76M	·	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-55M	$-44M	$-17M	$-24M	$-10M	$-118M	$-184M	$-74M	$-107M	$-97M	·	$-111M	$-72M	$-90M	$-100M	$-212M
Stockholders' Equity	$5.63B	$5.59B	$5.57B	$5.57B	$6.29B	$6.10B	$5.96B	$5.55B	$5.43B	$5.34B	$5.25B	$5.10B	$5.01B	$4.99B	$4.86B	$4.59B
Liabilities + Equity	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Shares Outstanding	·	682,900,000	682,000,000	681,900,000	681,600,000	681,500,000	680,800,000	680,600,000	679,600,000	679,200,000	·	676,300,000	675,700,000	675,100,000	·	674,200,000

Flusso di cassa 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$106M	$105M	$103M	$104M	$103M	$100M	$101M	$102M	$103M	$100M	$101M	$98M	$103M	$101M	$101M	$101M
Stock-based Comp	$15M	$9M	$11M	$7M	$16M	$12M	$11M	$12M	$11M	$13M	$9M	$10M	$9M	$13M	$10M	$12M
Deferred Tax	$16M	$-10M	$50M	$-12M	$-18M	$-12M	$28M	$-23M	$-35M	$-18M	$-78M	$-29M	$-38M	$-26M	$-7M	$-22M
Restructuring	·	·	$2M	$2M	·	·	$500.0K	$49M	·	·	$8M	$6M	$7M	$5M	$-200.0K	$1M
Operating Cash Flow	$178M	$59M	$153M	$207M	$154M	$109M	$173M	$245M	$281M	$142M	$252M	$231M	$168M	$220M	$206M	$258M
CapEx	$38M	$34M	$36M	$36M	$30M	$28M	$28M	$41M	$46M	$35M	$51M	$38M	$30M	$28M	$34M	$39M
Investing Cash Flow	$-37M	$-33M	$-40M	$-33M	$-29M	$-29M	$558M	$-40M	$-45M	$-34M	$-50M	$-37M	$-29M	$-27M	$-33M	$4M
Debt Issued	·	·	$1.04B	$68M	$0	$0	$0	$-12M	$-29M	$41M	$0	$0	$0	$0	$82M	$35M
Net Debt Issued	·	$-105M	·	·	·	$-31M	·	·	·	$-169M	·	·	·	$-270M	·	·
Financing Cash Flow	$-112M	$-107M	$700.0K	$-370M	$-7M	$-34M	$-755M	$-199M	$-197M	$-130M	$-184M	$-188M	$-196M	$-275M	$-82M	$-219M
Net Change in Cash	$28M	$-86M	$114M	$-198M	$134M	$54M	$-46M	$14M	$38M	$-28M	$27M	$-100.0K	$-58M	$-78M	$109M	$27M
Taxes Paid	$30M	$10M	$29M	$22M	$77M	$17M	$120M	$42M	$69M	$17M	$29M	$69M	$113M	$14M	$75M	$51M
Free Cash Flow	·	$25M	·	·	·	$81M	·	·	·	$107M	·	·	·	$192M	·	·
Levered FCF	·	$-8M	·	·	·	$50M	·	·	·	$59M	·	·	·	$134M	·	·

Redditività 8

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	31.7%	31.7%	·	32.4%	32.9%	33.8%	·	32.9%	34.2%	34.0%	·	33.6%	33.8%	35.1%	·	35.0%
Operating Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
Net Margin	2.2%	2.7%	·	-43.8%	3.8%	4.1%	·	3.4%	5.5%	3.6%	·	6.3%	-0.42%	6.8%	·	9.0%
Pretax Margin	4.8%	3.5%	·	-42.5%	4.9%	5.4%	·	4.3%	6.7%	4.8%	·	7.9%	-0.07%	8.8%	·	11.2%
EBITDA Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
ROA	0.31%	0.36%	·	-5.8%	0.51%	0.51%	·	0.45%	0.72%	0.46%	·	0.84%	-0.06%	0.89%	·	1.3%
ROE	0.64%	0.74%	·	-12.8%	1.1%	1.1%	·	1.1%	1.8%	1.2%	·	2.2%	-0.15%	2.6%	·	3.8%
ROIC	0.61%	0.83%	·	-7.1%	0.97%	1.1%	·	0.92%	1.4%	1.0%	·	1.6%	3.7%	1.6%	·	2.1%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	1.5	1.0	1.1	·	1.5	1.6	1.6	·	1.6	1.6	1.6	·	1.6
Quick Ratio	1.0	1.0	·	0.9	0.6	0.7	·	0.8	1.0	0.9	·	0.9	0.9	0.9	·	1.0
Debt / Equity	0.7	0.7	·	0.7	0.7	0.7	·	0.9	0.9	1.0	·	1.1	1.2	1.2	·	1.3
LT Debt / Equity	0.7	0.7	·	0.7	0.5	0.5	·	0.8	0.9	0.9	·	1.0	1.1	1.1	·	1.3
Interest Coverage	3.1	2.3	·	-14.7	3.0	3.5	·	2.6	2.9	2.3	·	2.9	1.0	3.1	·	4.1

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	1.4	1.4	·	1.4	1.4	1.3	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.4
Receivables Turnover	1.5	1.4	·	1.5	1.5	1.4	·	1.5	1.5	1.4	·	1.4	1.4	1.4	·	1.5

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$8.18	·	$8.17	$9.22	$8.95	·	$8.16	$8.00	$7.86	·	$7.54	$7.42	$7.40	·	$6.81
Revenue / Share	$2.50	$2.34	·	$2.38	$2.47	$2.32	·	$2.51	$2.49	$2.47	·	$2.54	$2.58	$2.63	·	$2.73
Cash Flow / Share	·	$0.09	·	·	·	$0.16	·	·	·	$0.21	·	·	·	$0.32	·	·
Cash / Share	·	$0.41	·	$0.37	$0.66	$0.46	·	$0.42	$0.40	$0.35	·	$0.35	$0.35	$0.44	·	$0.39
EPS (TTM)	$-0.84	$-0.81	·	$-0.13	$0.99	$1.04	·	$0.45	$0.53	$0.38	·	$0.53	$0.62	$0.91	·	$0.93

Valutazione (TTM) 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$6.56B	$6.55B	·	$6.58B	$6.67B	$6.69B	·	$6.82B	$6.83B	$6.87B	·	$7.04B	$7.18B	$7.34B	·	$7.62B
Net Income TTM	$-578M	$-551M	·	$-82M	$687M	$716M	·	$310M	$360M	$260M	·	$364M	$423M	$618M	·	$639M
Market Cap	·	$5.35B	·	$8.51B	$9.17B	$11.05B	·	$17.61B	$14.41B	$17.37B	·	$14.26B	$13.88B	$14.27B	·	$13.21B
Enterprise Value	·	$8.89B	·	$12.12B	$12.97B	$14.84B	·	$22.24B	$19.25B	$22.46B	·	$19.65B	$19.53B	$20.04B	·	$19.14B
P/E	-11.8	-9.7	·	-96.0	13.6	15.6	·	57.5	40.0	67.3	·	39.8	33.1	23.2	·	21.1
P/S	·	0.8	·	1.3	1.4	1.7	·	2.6	2.1	2.5	·	2.0	1.9	1.9	·	1.7
P/B	·	1.0	·	1.5	1.5	1.8	·	3.2	2.7	3.3	·	2.8	2.8	2.9	·	2.9
P / Cash Flow	·	91.2	·	·	·	101.1	·	·	·	122.6	·	·	·	65.0	·	·
EV / Revenue	·	1.4	·	1.8	1.9	2.2	·	3.3	2.8	3.3	·	2.8	2.7	2.7	·	2.5
Earnings Yield	-8.5%	-10.3%	·	-1.0%	7.4%	6.4%	·	1.7%	2.5%	1.5%	·	2.5%	3.0%	4.3%	·	4.7%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B
Margine Lordo %	32.6%	33.6%	33.9%	34.6%	33.9%
Margine Operativo %	-3.8%	16.0%	10.0%	15.0%	13.2%
Utile netto	$-530M	$712M	$321M	$686M	$573M
EPS Diluito	$-0.78	$1.04	$0.47	$1.01	$0.85

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.7	0.7	1.1	1.3	1.7
Rapporto corrente	1.8	1.1	1.6	1.6	1.7
Quick Ratio	1.0	0.6	1.0	1.0	1.1

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$495M	$692M	$724M	$710M	$842M

Proprietari istituzionali (13F) 493 filer · $7.6B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 493

Valore detenuto $7.6B

Nuove posizioni 97

Posizioni chiuse 60

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
97 (-7 vs trimestre precedente)	60 (-11 vs trimestre precedente)	192 (+31 vs trimestre precedente)	113 (-15 vs trimestre precedente)	+24.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
Dodge & Cox	$1.188.207.643	120.020.974	15,59%	Azioni
VANGUARD GROUP INC	$743.810.028	64.904.889	9,76%	Azioni
BlackRock, Inc.	$695.784.194	70.281.231	9,13%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$310.298.175	31.343.250	4,07%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$304.948.067	30.802.835	4,00%	Azioni
GREENHAVEN ASSOCIATES INC	$243.909.369	24.637.310	3,20%	Azioni
STATE STREET CORP	$213.572.443	21.572.974	2,80%	Azioni
DIMENSIONAL FUND ADVISORS LP	$202.086.268	20.412.181	2,65%	Azioni
Engine Capital Management, LP	$196.622.217	19.860.830	2,58%	Azioni
BARROW HANLEY MEWHINNEY & STRAUSS LLC	$195.386.083	19.735.968	2,56%	Azioni
New Mountain Capital, L.L.C.	$138.600.000	14.000.000	1,82%	Azioni
Invesco Ltd.	$137.465.065	13.885.360	1,80%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$130.519.321	13.180.567	1,71%	Azioni
MARSHALL WACE, LLP	$129.988.565	13.130.158	1,71%	Azioni
AQR CAPITAL MANAGEMENT LLC	$115.112.902	11.627.566	1,51%	Azioni
BANK OF AMERICA CORP /DE/	$108.794.506	10.989.344	1,43%	Azioni
EARNEST PARTNERS LLC	$106.410.397	10.748.525	1,40%	Azioni
LONDON CO OF VIRGINIA	$103.811.008	10.485.960	1,36%	Azioni
FULLER & THALER ASSET MANAGEMENT, INC.	$101.537.816	10.256.345	1,33%	Azioni
D. E. Shaw & Co., Inc.	$94.758.077	9.571.523	1,24%	Azioni
First Pacific Advisors, LP	$81.088.326	8.190.740	1,06%	Azioni
SEI INVESTMENTS CO	$78.677.367	7.947.198	1,03%	Azioni
FMR LLC	$77.670.074	7.845.462	1,02%	Azioni
GENDELL JEFFREY L	$75.311.973	7.607.270	0,99%	Azioni
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$73.188.967	7.392.825	0,96%	Azioni
Clarkston Capital Partners, LLC	$67.214.209	6.789.314	0,88%	Azioni
MORGAN STANLEY	$66.905.804	6.758.161	0,88%	Azioni
GOLDMAN SACHS GROUP INC	$61.422.976	6.204.341	0,81%	Azioni
NORGES BANK	$60.307.949	6.091.712	0,79%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$57.627.950	5.821.005	0,76%	Azioni
NORTHERN TRUST CORP	$56.753.512	5.732.678	0,74%	Azioni
Freestone Grove Partners LP	$56.577.352	5.714.884	0,74%	Azioni
UBS Group AG	$56.155.742	5.672.297	0,74%	Azioni
AMERIPRISE FINANCIAL INC	$54.696.928	5.524.942	0,72%	Azioni
YACKTMAN ASSET MANAGEMENT LP	$47.223.000	4.770.000	0,62%	Azioni
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	$46.782.232	4.725.478	0,61%	Azioni
Brickwood Asset Management LLP	$45.515.438	4.597.519	0,60%	Azioni
VANGUARD FIDUCIARY TRUST CO	$42.790.226	4.322.245	0,56%	Azioni
JONES FINANCIAL COMPANIES LLLP	$42.363.659	4.120.981	0,56%	Azioni
Bank of New York Mellon Corp	$40.800.098	4.121.222	0,54%	Azioni
ROYCE & ASSOCIATES LP	$36.393.232	3.676.084	0,48%	Azioni
FRONTIER CAPITAL MANAGEMENT CO LLC	$34.719.001	3.506.970	0,46%	Azioni
PRIVATE MANAGEMENT GROUP INC	$30.662.617	3.097.234	0,40%	Azioni
Voss Capital, LP	$26.235.000	2.650.000	0,34%	Azioni
Prescott General Partners LLC	$25.740.000	2.600.000	0,34%	Azioni
Gotham Asset Management, LLC	$24.912.796	2.516.444	0,33%	Azioni
Quantinno Capital Management LP	$24.177.175	2.442.138	0,32%	Azioni
KINNEY ASSET MANAGEMENT, LLC	$23.025.600	1.845.000	0,30%	Azioni
Loews Corp	$21.780.000	2.200.000	0,29%	Azioni
Western Standard LLC	$20.888.842	2.109.984	0,27%	Azioni

Mostra tutti i 493 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 depositi	07 Maggio 2021	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 47 insider · 29 dirigenti · 20 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Netto 12m
Emmanuel Ligner	President and CEO	18 Agosto 2026 F	737.334	1	$993.125
Michael Stubblefield	President & CEO	21 Maggio 2025 G	545.500	0	$0
Todd W. Garner	EVP and CFO	21 Settembre 2026 A	49.688	0	$0
Brent R. Jones	EVP, Chief Financial Officer	23 Febbraio 2026 F	419.782	0	$0
Thomas A Szlosek	EVP & CFO	17 Maggio 2023 F	77.489	0	$0
Corey Walker	President, VWR Dist. & Servs.	21 Giugno 2026 F	384.535	0	$0
Mary Blenn	EVP, Chief Operating Officer	19 Febbraio 2026 A	253.384	0	$0
Bjorn Hofman	EVP and COO	21 Maggio 2019 A	157.143	0	$0
Brittany Hankamer	EVP, Chief HR Officer	14 Agosto 2026 F	248.864	0	$0
Steven W Eck	SVP & Chief Accounting Officer	31 Luglio 2026 F	129.593	0	$0
Claudius Sokenu	EVP, Chief Legal & Compliance	24 Luglio 2026 F	251.228	0	$0
Ludovic Brellier	EVP, Bioscience & Medtech	01 Maggio 2026 A	146.566	0	$0
Benoit Gourdier	EVP, Bioscience & Medtech	23 Febbraio 2026 F	362.859	0	$0
Christophe Couturier	EVP, AMEA	08 Agosto 2025 A	211.271	0	$0
James Bramwell	EVP Sales, Customer Excellence	27 Febbraio 2025 S	86.605	0	$0
Kitty Sahin	EVP, Strategy&Corp Development	18 Luglio 2024 F	42.274	0	$0
Randy Lee Stone	EVP, Laboratory Solutions	16 Aprile 2024 F	68.105	0	$0
Sheri Lewis	EVP, Global Ops & Supply Chain	31 Dicembre 2023 F	70.692	0	$0
Frederic Vanderhaegen	EVP, Americas and Europe	25 Agosto 2023 S	160.735	0	$0
Justin Miller	EVP & General Counsel	17 Maggio 2023 F	93.336	0	$0
Gerard Brophy	EVP, Biopharma Production	17 Maggio 2023 F	89.032	0	$0
Meghan Henson	EVP, Chief HR Officer	24 Febbraio 2023 A	40.184	0	$0
Michael Wondrasch	EVP & CIO	20 Febbraio 2023 F	96.072	0	$0
Mark Christopher Murray	EVP, Biomaterials & AT	13 Gennaio 2022 F	18.680	0	$0
Devashish Ohri	EVP, IMEA	27 Maggio 2021 M	139.095	0	$0
Sven Henrichwark	EVP, APAC Region	25 Febbraio 2021 A	19.802	0	$0
Eric Mcallister	EVP, CHRO	17 Maggio 2020 F	197.899	0	$0
Tanya Foxe	EVP, Operations & Supply Chain	21 Febbraio 2020 A	39.458	0	$0
Ashish Kulkarni	EVP and Chief Technology Officer	21 Maggio 2019 A	128.571	0	$0
Gregory T Lucier	Direttore	08 Maggio 2026 P	60.000	2	$541.200
Simon Dingemans	Direttore	07 Maggio 2026 A	31.495	1	$203.500
Louise Makin	Direttore	07 Maggio 2026 A	47.140	0	$0
Mala Murthy	Direttore	07 Maggio 2026 A	69.479	0	$0
Michael Severino	Direttore	07 Maggio 2026 A	85.821	0	$0
Joseph R Massaro	Direttore	07 Maggio 2026 A	77.408	0	$0
Gregory L Summe	Direttore	07 Maggio 2026 A	83.381	2	$2.065.000
Sanjeev K Mehra	Direttore	07 Maggio 2026 A	33.376	2	$4.882.750
John Carethers	Direttore	08 Maggio 2025 A	45.858	0	$0
Lan Kang	Direttore	08 Maggio 2025 A	52.315	0	$0
Juan Andres	Direttore	08 Maggio 2025 A	65.480	0	$0
Jonathan M Peacock	Direttore	08 Maggio 2025 A	219.815	0	$0
Christi Shaw	Direttore	11 Maggio 2023 A	36.271	0	$0
Matthew S. Holt	Direttore	12 Maggio 2022 A	7.908	0	$0
Rajiv Gupta	Direttore	01 Aprile 2022 A	780.562	0	$0
Jo Natauri	Direttore	12 Luglio 2021 P	557.656	0	$0
Rakesh Sachdev	Direttore	25 Febbraio 2021 A	32.841	0	$0
Thomas Connolly	Direttore	18 Giugno 2020 S	72.620.082	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 56 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
LSEQ · Harbor ETF Trust	2,52%	27.960 NS	31 Luglio 2026	N-PORT
EPSB · Harbor ETF Trust	1,77%	6.133 NS	31 Luglio 2026	N-PORT
BSJS · Invesco Exchange-Traded Self-Indexe…	1,51%	11.851.000	02 Ottobre 2026	Giornaliero
DFSV · Dimensional ETF Trust	0,52%	3.118.943 NS	31 Luglio 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,40%	25.471 NS	31 Luglio 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0,39%	586.296 SH	19 Agosto 2026	Giornaliero
QVMM · Invesco Exchange-Traded Fund Trust …	0,32%	88.836 SH	02 Ottobre 2026	Giornaliero
RWK · Invesco Exchange-Traded Fund Trust …	0,27%	230.747 SH	02 Ottobre 2026	Giornaliero
VFVA · VANGUARD WELLINGTON FUND	0,27%	233.604 SH	19 Agosto 2026	Giornaliero
PTMC · Pacer Funds Trust	0,27%	75.616 NS	31 Luglio 2026	N-PORT
NUSC · Nushares ETF Trust	0,20%	188.520 NS	31 Luglio 2026	N-PORT
MIDU · Direxion Shares ETF Trust	0,20%	10.027 NS	31 Luglio 2026	N-PORT
ESML · iShares Trust	0,20%	376.218 SH	11 Settembre 2026	Giornaliero
BBMC · J.P. Morgan Exchange-Traded Fund Tr…	0,19%	286.321 NS	31 Luglio 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0,19%	1.104.592 SH	19 Agosto 2026	Giornaliero
DFAT · Dimensional ETF Trust	0,17%	1.765.932 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,17%	1.854.609 NS	31 Luglio 2026	N-PORT
IYH · iShares Trust	0,16%	386.410 SH	11 Settembre 2026	Giornaliero
VBR · VANGUARD INDEX FUNDS	0,14%	9.920.672 SH	19 Agosto 2026	Giornaliero
SMMD · iShares Trust	0,14%	351.599 SH	11 Settembre 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,13%	313.238 NS	31 Luglio 2026	N-PORT
REVS · Columbia ETF Trust I	0,12%	28.653 NS	31 Luglio 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,10%	1.983.361 SH	19 Agosto 2026	Giornaliero
IWS · iShares Trust	0,10%	978.878 SH	11 Settembre 2026	Giornaliero
EQAL · Invesco Exchange-Traded Fund Trust …	0,10%	50.803 SH	02 Ottobre 2026	Giornaliero
WSML · iShares Trust	0,09%	41.659 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,08%	7.835.858 SH	19 Agosto 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,08%	15.636.784 SH	19 Agosto 2026	Giornaliero
TILT · FlexShares Trust	0,08%	121.976 NS	31 Luglio 2026	N-PORT
RECS · Columbia ETF Trust I	0,08%	325.274 NS	31 Luglio 2026	N-PORT
IWR · iShares Trust	0,07%	2.700.866 SH	11 Settembre 2026	Giornaliero
IUS · Invesco Exchange-Traded Self-Indexe…	0,06%	37.709 SH	02 Ottobre 2026	Giornaliero
PRF · Invesco Exchange-Traded Fund Trust	0,04%	251.941 SH	02 Ottobre 2026	Giornaliero
IUSV · iShares Trust	0,03%	593.664 SH	11 Settembre 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,03%	11.452 NS	31 Luglio 2026	N-PORT
IWD · iShares Trust	0,03%	1.462.438 SH	11 Settembre 2026	Giornaliero
VONV · VANGUARD SCOTTSDALE FUNDS	0,02%	397.791 SH	19 Agosto 2026	Giornaliero
IYY · iShares Trust	0,01%	29.349 SH	11 Settembre 2026	Giornaliero
IWB · iShares Trust	0,01%	457.613 SH	11 Settembre 2026	Giornaliero
ITOT · iShares Trust	0,01%	885.606 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,01%	183.968 SH	11 Settembre 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,01%	21.681.946 SH	19 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,01%	534.809 SH	19 Agosto 2026	Giornaliero
VONE · VANGUARD SCOTTSDALE FUNDS	0,01%	109.164 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,01%	55.632 SH	19 Agosto 2026	Giornaliero
ESGV · VANGUARD WORLD FUND	0,01%	149.286 SH	19 Agosto 2026	Giornaliero
NEAR · iShares U.S. ETF Trust	0,01%	365.000 SH	09 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	5.257 NS	31 Luglio 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	544 NS	31 Luglio 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	1.476 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	2.958 NS	31 Luglio 2026	N-PORT
IJH · iShares Trust	·	23.957.709 SH	11 Settembre 2026	Giornaliero
IJJ · iShares Trust	·	3.487.441 SH	31 Agosto 2026	Giornaliero
XJH · iShares Trust	·	93.400 SH	08 Settembre 2026	Giornaliero
ISCB · iShares Trust	·	29.420 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	144.718 SH	11 Settembre 2026	Giornaliero

AVTR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 25 analisti MANTIENI

Target mediano $14.20 -10,2%

3 12,0% Acquisto forte

5 20,0% Compra

16 64,0% Mantieni

1 4,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

14 analisti · 2026-10-05

Target medio $14.56 -7,9%

Ora Prezzo attuale $15.81

Basso$12.00 Media$14.56 Alto$19.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	·
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
TECH	$11.03B	60.9	-0.38%	15.0%	9.0%	65.8%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BIO	·	·	·	·	·	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·

Ultime notizie Notizie recenti che menzionano questa società

23

RBC Capital Inizia Avantor (AVTR) Con Valutazione Sector Perform Yahoo Finance · 4 mesi fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

AVTR Avantor, Inc. Common Stock